Independent Advisory Committee

Prior to working with the EAPM, Denis worked with the European Cancer Patient Coalition and in the European Parliament on broad array of health issues relating to the pharmaceutical area and patient issues. He has also worked in international NGOs on health development projects in Afghanistan, Mexico and Palestine. Over the course of his career, Denis has developed numerous public affairs initiatives in the areas of advocacy, social marketing, policy support and launch, policy development and media relations.

He has >20 years’ experience in drug/therapeutics development across industry and academic careers focused in clinical drug development, clinical and translational science, and precision medicine (oncology, inflammation, cardio-/vascular). I have broad clinical development experience from Ph.1 – Ph.3, through registration to commercialisation (small molecules, biologics, gene/cell therapies), coupled with varied commercial experience (industry, biotech, commercialised own IP). I maintain an academic profile as Visiting Professor Division Cancer Studies King’s College London, Fellow Royal College Pathologists, and serving on numerous National and International review panels and advisory boards.

From 1996 to 2008 A. Metspalu was also the head and founder of the MD Center of the Tartu University Hospital. Metspalu is the past (2006) president of the European Society of the Human Genetics. 2010 he was elected to the Estonian Academy of Sciences and in 2019 he was nominated as a “Estonian European of the Year” Award.

His H-index is 115. He is serving in several national (MSC of Estonian Personal Medicine Project) and international committees (Board member of Mission for Cancer in Horizon Europe) and has received among other awards and honors the Order of the Estonian Red Cross 3rd Class and L’Ordre des Palmes Academiques from the Republic of France. From 2010, he is Doctor Honoris Causa of Vilnius University.

She has a PhD in cell biology and a Masters degree in patent law. Among her other roles, she is chair of the National Health and Medical Research Council Embryo Research Licensing Committee and a member of the Australian Genomics Health Futures Mission Expert Advisory Committee and the Australian Advisory Council on Medicinal Use of Cannabis. She is a fellow of the Australian Academy of Law. Dianne is Director of the Centre for Law and Genetics (CLG) at the University of Tasmania. The broad theme of the CLG’s research is the regulation and governance of biomedicine, human genetics and genomics, and stem cell technology. The CLG team was established 25 years ago and currently numbers 17 faculty, postdoctoral fellows, PhD candidates and research assistants as well as broad range of international collaborators. Dianne’s current research focuses primarily on the regulation and governance of personalized medicine, genomic data sharing, biobanking, genome editing and other emerging technologies, together with commercialisation of biotechnology and patenting of biotechnological inventions. She currently leads two projects funded by the Australian Research Council discovery grants program, one on the legal, research ethics and social issues associated with genomic data sharing and the other on the regulation of innovative health technologies. Her other major current research projects focus on genome editing, with particular focus on strategies for facilitating citizen deliberation, funded by the Australian Research Council and the Genomics Health Futures Mission.

After joining Seoul National University College of Medicine as a professor in biochemistry, he worked on genomic analysis of various human diseases using microarray and NGS. He moved to Samsung Medical Center and Sungkyunkwan University to lead the clinical genomics research as a director of Samsung Genome Institute. He established personalized genome analysis platform for cancer and genetic disorders to interpret patient genome for personalized healthcare. He is also working on single cell genomics to understand tumor evolution and microenvironment in colon, lung and breast cancers.

He frequently writes and speaks on topics related to each of these areas. In connection with the COVID-19 pandemic, David has also been providing guidance on a variety of privacy and regulatory issues related to development of diagnostic tests and mobile applications, research studies, and general health care compliance.

In addition to his advisory practice, David regularly works with members of the firm’s private equity group in conducting regulatory diligence of private equity investments in the clinical research space. He also collaborates with members of the firm’s litigation practice on government investigations involving the clinical research enterprise. Prior to attending law school, David worked as a project manager for a leading supplier of electronic medical records.

She is Full Professor of General Psychology at the University of Milan, and the Coordinator of Doctorate FOLSATEC at the European School of Molecular Medicine. She is also the Coordinator of Psychology training and development at LILT.

She is member of various prestigious academic associations.

Her research activities are almost entirely conducted at the IEO, at both national and international level.

Her research activities especially focus on cognitive processes, decision- making and error prevention. With particular attention to the medical field, medical humanities, health and centrality of patient.

Having a reputation for developing novel partnerships and improving consumer outcomes through innovative and high-quality service delivery; she has been acknowledged for her innovation in the not-for-profit sector as the winner of the 2013 Telstra Businesswomen’s Award in Victoria, Australia for Business Innovation.

Currently, the CEO of Crohn’s & Colitis Australia her executive career has involved leading change and transformative growth in not-for-profit organisations in health, health professional regulation, disability and community sectors. She has been a non-executive director of 15 companies and chair of 4 including Eastern Melbourne Medicare Local, Australian Nursing Council, ENBIS Pty Ltd (an IT marketing company) and ISPID, the International Society for the study and Prevention of Infant Death.

Leanne has qualifications in Science (chemistry and mathematics), Business Management, Nursing, Education, Data Science, Law Enforcement and Investigations, and Company directorship. In 2014 she was honoured to be appointed as an adjunct Associate Professor with the University of the Sunshine Coast Queensland, Faculty of Science, Health, Education and Engineering.

He previously worked at the Department of Law and the Sheffield Institute of Biotechnological Law and Ethics in the University of Sheffield. In legal philosophy, he studies the relationship between law, ethics and manners; the theory of politeness (Shaftesbury, 1711); and, the concepts of property, privacy, and the public interest. He studies these in relation to data protection, particularly health data in clinical and research settings; patient rights; governance of life science research; and, governance of and through data science.